This page has moved! Click here to view the most up-to-date version of this page on the White Rose Wiki.
Qu Biologics, Inc. is a Canadian biotechnology company based in Burnaby, British Columbia.
Qu Biologics was founded in 2007 by Hal Gunn and Rob Freeman.[1]
On December 18, 2020, National Research Council Canada announced up to $109,764.00 in funding through the Industrial Research Assistance Program (NRC IRAP) to Qu Biologics "for a project to provide proof-of-concept evidence for the safety and efficacy of a preventative treatment as well as therapeutic use of a treatment to protect the lungs and prevent serious COVID-19 infection."[2]
Qu Biologics is a member organization of the Biotechnology Innovation Organization (BIO) and N2 Canada.[3][4]
Since 2007, Qu Biologics has “raised over CAD$40 million in funding from private investors and government funding”.[5]
The company has received grants and investment funding from:[6][7]
Our History. Qu Biologics Inc. Retrieved May 1, 2023, from http://archive.today/2023.05.01-205011/https://www.qubiologics.com/who-we-are/our-history/ ↩︎
National Research Council of Canada supports development of 4 COVID-19 therapeutic candidates. (2020, December 18). Government of Canada. http://archive.today/2023.09.06-231214/https://www.canada.ca/en/national-research-council/news/2020/12/national-research-council-of-canada-supports-development-of-4-covid-19-therapeutic-candidates.html ↩︎
BIO Member Directory. Biotechnology Innovation Organization. Retrieved September 30, 2022, from https://web.archive.org/web/20220930103715/https://www.bio.org/bio-member-directory ↩︎
Members. N2 Canada. Retrieved October 11, 2022, from http://archive.today/2022.10.11-054124/https://n2canada.ca/members/ ↩︎
Our History. Qu Biologics Inc. Retrieved May 1, 2023, from http://archive.today/2023.05.01-205011/https://www.qubiologics.com/who-we-are/our-history/ ↩︎
Qu Biologics Inc. - Funding, Financials, Valuation & Investors. Crunchbase. Retrieved May 1, 2023, from https://www.crunchbase.com/organization/qu-biologics-inc/company_financials ↩︎
Portfolio. ACA Group. Retrieved May 1, 2023, from http://archive.today/2023.05.01-212531/https://aca-investments.com/portfolio/ ↩︎
Experience | Dave Lopez. LinkedIn. Retrieved July 19, 2023, from http://archive.today/2023.07.19-225940/https://www.linkedin.com/in/dave-lopez-7b2306193/details/experience/ ↩︎
Home. Integro Capital. Retrieved July 19, 2023, from http://archive.today/2023.07.19-230516/https://integrocap.com/ ↩︎
Management Team. Qu Biologics Inc. Retrieved May 2, 2023, from https://web.archive.org/web/20230502003205/https://www.qubiologics.com/who-we-are/management-team/ ↩︎
Board of Directors. Qu Biologics Inc. Retrieved May 2, 2023, from https://web.archive.org/web/20230502044842/https://www.qubiologics.com/who-we-are/board-of-directors/ ↩︎
Scientific Advisory Board. Qu Biologics Inc. Retrieved May 7, 2023, from https://web.archive.org/web/20230507165939/https://www.qubiologics.com/who-we-are/scientific-advisory-board/ ↩︎
IBD Clinical Advisors. Qu Biologics Inc. Retrieved May 7, 2023, from https://web.archive.org/web/20230507171856/https://www.qubiologics.com/who-we-are/clinical-advisors/ ↩︎